HealthEast Clinical Trials

HealthEast provides patients with opportunities to participate in clinical research trials. Clinical trials are Food and Drug Administration (FDA)-required projects that involve testing promising new medications and medical devices. This type of research is at the heart of all medical advances. Studies may research new drugs, new surgical procedures or devices, or new ways to use existing treatments.

The goal of these clinical trials is to determine if a new treatment works and is safe. Carefully conducted clinical trials are the fastest way to find treatments that work in people and improve health.

Clinical trials are an important part of health care, offering patients access to new medicines and devices years before they are available nationally. Participants in these trials:

  • Can play a more active role in their own health care
  • Gain access to new research treatments before they are widely available
  • Help others by contributing to medical research

Learn more about our Clinical Trials Office.

Proud to be a MAGI Blue Ribbon Site

HealthEast clinical trials program has been designated a Blue Ribbon Site by Model Agreements and Guidelines International (MAGI), an organization dedicated to promoting clinical research best practices. This award signifies that HealthEast’s clinical research program has achieved a culture of excellence. Excellent sites exhibit the following characteristics: 

  • Experience
  • Stability
  • Quick study start-up
  • Access to a large patient database
  • Enrollment commitments consistently met or exceeded
  • High-quality data generated in a timely manner

We are looking for volunteers for the following clinical trials:

Anemia and chronic kidney disease

This research study is evaluating the ability of an investigational medication to increase hemoglobin levels in patients with chronic kidney disease. The investigational medication, called Vadadustat, is an oral pill compared to the currently available and approved injectable treatments for anemia. There will be office visits every two weeks during the first three months of the study, then monthly and quarterly thereafter.
To be eligible for this trial, participants must have:
  • Chronic kidney disease, not on dialysis
  • Low hemoglobin levels (anemia)
  • No active cancer, bone marrow disease, or active bleeding problems
Our research patients are closely monitored by our cardiologists, nurses, and research team. The study medication and all study-related procedures and physical exams are provided at no cost. You will be reimbursed $52 for each study visit; valet parking is provided at no cost.
To get started, complete the Clinical Trials Interest Form, or call 651-326-4448 for more information.

Heart failure

The purpose of this research study is to test if an investigational medication, compared to a standard medication, is safe and effective in reducing the complications of heart failure. These could include hospitalization for heart failure and death from cardiovascular causes. There will be office visits every four to six months during this four to five-year study.
To participate in this clinical trial, patients must be:
  • 55 years of age or older
  • Diagnosed with heart failure
Our research patients are closely monitored by our cardiologists, nurses, and research team. The study medication and all study-related procedures and physical exams are provided to you at no cost. You will be reimbursed $50 for each study visit. Valet parking is provided at no cost.
To get started, complete the Clinical Trials Interest Form, or call 651-326-4448 for more information.

Statin intolerance

The purpose of this research study is to test if an investigational non-statin medication, compared to a placebo, is safe and effective for reducing major cardiovascular disease events in patients who are statin intolerant. 

Approximately 12,604 participants are planned for this study with a treatment period between two and five years.  There will be six office visits at the study center. Then after month six, participants will alternate between telephone visits and in-clinic visits every three months until the end of the study.
To participate in this clinical trial, patients must have:
  • Statin intolerance (unable to tolerate full recommended doses of medications like Lipitor®/atorvastatin and Crestor®/Rosuvastatin)
  • High LDL cholesterol
  • History of or high risk for cardiovascular disease (heart attack, stroke, peripheral arterial disease, etc.)
Our research patients are closely monitored by our cardiologists, nurses, and research team. The study medication and all study-related procedures and physical exams are provided to you at no cost. You will be reimbursed $50 for each study visit. Valet parking is provided at no cost. 
To get started, complete the Clinical Trials Interest Form, or call 651-326-4448 for more information.

Type 2 diabetes and high triglycerides

The purpose of this research study is to test if an investigational medication, compared to a placebo, is safe and effective for cardiovascular disease prevention in patients with Type 2 diabetes and high triglyceride levels in their blood. Approximately 10,000 participants are planned for this study involving 20 office visits and 16 telephone visits over the course of up to five years.
To participate in this study, patients must have:
  • Type 2 diabetes diagnosis
  • High triglyceride levels in the blood
Our research patients are closely monitored by our cardiologists, nurses, and research team. The study medication and all study-related procedures and physical exams are provided to you at no cost. You will be reimbursed $50 for each study visit; valet parking is provided at no cost. 
To get started, complete the Clinical Trials Interest Form, or call 651-326-4448 for more information.